Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial
Pain Research and Management · 2026-01 · 2026 (1)
DOI: 10.1155/prm/2881787 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Pain Research and Management, online erschienen am 27.04.2026. Verfasst von Chenfang Miao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China. Hauptthemen laut MEDLINE: Kyphoplasty, Analgesics, Analgesia. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Medical University.
Abstract (Originalsprache)
Background
As a G protein‐biased μ‐opioid receptor agonist, oliceridine can offer a relatively effective and safe analgesia. However, its effect on patients suffering from kyphoplasty was unexplored.
Aim
This study was aimed to determine the median effective dose (ED 50 ) of oliceridine for analgesia during kyphoplasty in elderly patients across different age groups, providing clinical evidence for the optimal administration method.
Methods
This prospective study included a total of 105 elderly patients with osteoporotic vertebral compression fractures (OVCFs) who underwent elective percutaneous kyphoplasty (PKP). The included subjects were divided into young age group (65–74 years old), middle age group (75–84 years old), and old age group (≥ 85 years old). The ED 50 of oliceridine was determined by Dixon’s up–down sequential method. The manifestations of intraoperative analgesic insufficiency were defined as a Numerical Rating Scale (NRS) score ≥ 4, presence of body movement, an increased heart rate, or systolic and diastolic blood pressure > 20% from baseline during balloon dilation or bone cement injection.
Results
When combined with remimazolam, the ED 50 value of oliceridine for intraoperative analgesia during PKP was 0.035, 0.030, and 0.027 mg/kg in the young age group, middle age group, and old age group, respectively. The required ED 50 in the young–old group was significantly higher than that in the old age group.
Conclusion
The ED 50 of oliceridine for intraoperative analgesia during PKP was varied from different age among these elderly patients. The lowest ED 50 value in the old age group suggested that an increasing age might be associated with enhanced analgesic potency of oliceridine. The specific mechanism needs to be further elucidated in the future. Trial Registration: Chinese Clinical Trial Register: ChiCTR2400095085
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.
- Department of Orthopaedics, Mindong Hospital Affiliated to Fujian Medical University, Fuan, 355000, Fujian, China.
ORCID-Profile: Chenfang Miao, Chengzhao Liu, Qingqing Huang, Bin Zou
Förderung
- Fujian Medical University
Zitieren
APA
Miao, C., Weng, D., Liu, C., Huang, Q., Chen, K., & Zou, B. (2026). Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/2881787
Vancouver
Miao C, Weng D, Liu C, Huang Q, Chen K, Zou B. Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/2881787
BibTeX
@article{Miao2026,
author = {Miao, Chenfang and Weng, Digui and Liu, Chengzhao and Huang, Qingqing and Chen, Kongning and Zou, Bin},
title = {Oliceridine for Analgesia in Elderly Patients Undergoing Kyphoplasty: From a Clinical Trial},
journal = {Pain Research and Management},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/prm/2881787}
}
EUVIMED